Device Y2K data
This article was originally published in The Gray Sheet
Manufacturers can expect to receive a letter from FDA in late February detailing the "additional product status information" the agency wants regarding both year 2000 compliant and non-compliant products. Firms "will be asked to provide more detailed identification of non-compliant products, as well as more detailed descriptions of how products will operate as a result of their uncorrected date problem," the agency says in a Jan. 13 posting on its website. For compliant products, manufacturers will be asked to "submit lists of their specific product models"
You may also be interested in...
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
As Chinese returnees transform their startups to fully-fledged biopharma operations with a full product lineup and the global market in sight, the journey has been filled with challenges. Based on interviews and on-the-ground reporting, this new series takes a closer look at several companies' experiences.
US FDA Will Need About A Week To Complete COVID Vaccine Assessment Following Advisory Cmte., CBER’s Marks Says
Timeline is the most pessimistic public projection to date, but still incredibly fast. Clinical trial patients on placebo could be contacted and offered the vaccine after an EUA is granted.